Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trinucleotide repeat-containing gene 6C protein (TNRC6C) is a member of the GW182 family of proteins, primarily functioning as an essential effector of miRNA-mediated gene silencing[1][2][3][5]. TNRC6C acts as a scaffold protein that interacts with Argonaute proteins in cytoplasmic processing bodies (P-bodies) to mediate translational repression and promote deadenylation and decay of target mRNAs[1][3][5]. It also recruits CCR4-NOT and PAN deadenylase complexes as part of this gene silencing process[1]. TNRC6C’s regulatory role influences cell proliferation, migration, invasion, and apoptosis in certain cancer types, such as papillary thyroid carcinoma, where its decreased expression is associated with tumorigenic progression[2]. While it is not a classic therapeutic target (such as a receptor or enzyme), its central role in post-transcriptional regulation makes it functionally significant in gene expression control and cancer biology[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trinucleotide repeat-containing gene 6C protein (TNRC6C).